Details for: CLINDAMYCIN IV INFUSION
Company: SANDOZ CANADA INCORPORATED
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02408511 | CLINDAMYCIN IV INFUSION | CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) | 12 MG / ML | SOLUTION | INTRAVENOUS |
02408538 | CLINDAMYCIN IV INFUSION | CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) | 18 MG / ML | SOLUTION | INTRAVENOUS |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
Clindamycin IV Infusion is used for the treatment of serious bacterial infections
What it does
Clindamycin IV Infusion provides clindamycin which interferes with protein synthesis in bacteria, thereby preventing growth of the bacteria causing your infection.
When it should not be used
You are allergic (hypersensitive) to:
- Clindamycin
- Lincomycin
- Other ingredients in the product (see list of nonmedicinal ingredients).
What the medicinal ingredient is
Clindamycin phosphate.
What the non-medicinal ingredients are
Dextrose monohydrate, disodium edetate dehydrated and water for injection. It may also contain hydrochloric acid and/or sodium hydroxide for pH adjustment.
What dosage form it comes in
Clindamycin IV Infusion is available in ready-to-use 50 mL minibags containing clindamycin premixed with 5% dextrose w/v as a sterile solution.
Each 100 mL minibag (filled with 50 mL) contains clindamycin phosphate equivalent to 300 mg, 600 mg or 900 mg clindamycin. The single dose minibags are available as follows:
300 mg/50 mL, Box of 10 minibags
600 mg/50 mL, Box of 10 minibags
900 mg/50 mL, Box of 10 minibags
Clindamycin IV Infusion is for intravenous infusion only.
Warnings and precautions
To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Clindamycin IV Infusion. Talk about any health conditions or problems you may have, including if you:
- have had intestinal disorders such as:
- colitis (inflammation of the colon)
- inflammatory bowel disease
- have diarrhea or get diarrhea when you take antibiotics
- suffer from problems with your stomach or intestines (e.g. bowel disease, colitis).
- suffer from problems with your kidneys or liver.
- are pregnant or planning to become pregnant. Clindamycin passes to the human fetus
- are breastfeeding or planning to breastfeed. Clindamycin is passed to the infant through human breast milk. Because of the potential for serious adverse reactions in nursing infants, clindamycin should not be administered to nursing mothers.
- you have glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and are taking primaquine. You may need to have routine blood tests while taking Clindamycin IV Infusion with primaquine, to monitor for potential blood cell changes.
Interactions with this medication
- erythromycin (an antibiotic)
- muscle relaxants used during operations
- primaquine (antimalarial)
- Aminoglycosides (a class of antibiotics)
- St-John’s Wort (Hypericum perforatum)
Proper use of this medication
The health care professional will administer Clindamycin IV Infusion and will:
- Decide:
- the dose and rate of administration of the medicine
- Ensure that:
- the medicine will be given as an injection (infusion) through the vein
- the medicine will be given for the full treatment period
- the medicine will be inspected to determine there is:
- no discolouration
- no leaks
- no solid particles floating in solution
- no haziness in the solution
Usual dose
Your doctor will determine the dose and for how long you should receive it.
Long term use of Clindamycin IV Infusion:
- If you have to use clindamycin for a long time, your doctor may arrange regular liver, kidney and blood tests.
- Do not miss these check-ups with your doctor.
- Long term use can also make you more likely to get other infections that do not respond to clindamycin treatment.
This particular product format in minibags is not suitable for use in children 12 years of age and under.
Overdose
Missed Dose
Your healthcare professional will ensure that this product is administered each day and doses are not missed, as it works best when there is a constant amount in the body. If the medicine is stopped too soon, your symptoms may return. If you feel a dose has been missed contact your healthcare professional.
Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by clindamycin phosphate or other antibacterial drugs in the future.
Side effects and what to do about them
These are not all the possible side effects you may feel when taking Clindamycin IV Infusion. If you experience any side effects not listed here, contact your healthcare professional. Please also see Warnings and Precautions.
Clindamycin IV Infusion can cause side effects such as:
- skin reddening, rash, itching, hives
- throat ulcers, sore throat
- feeling sick, being sick
- stomach pain and diarrhea
- injection site irritation
- thrombophlebitis (inflammation of the vein due to blood clot)
- low red blood cells (anemia) with symptoms such as bruising or bleeding
- low white blood cells (neutropenia) which can lead to an increased chance of infections
- vaginal infection or vaginitis (inflamed vagina)
Contact your doctor immediately if the following happens:
- you have symptoms of a severe allergic reaction such as:
- sudden wheeziness
- difficulty in breathing
- swelling of eyelids, face or lips
- rash or itching (especially affecting the whole body)
- blistering and peeling of large areas of skin
- fever
- cough
- feeling unwell
- swelling of the gums, tongue or lips
- you have symptoms of liver problems such as:
- yellowing of the skin and whites of the eyes (jaundice).
- you have symptoms of Clostridium difficile colitis (bowel inflammation) such as:
- severe, persistent, watery or bloody diarrhea with or without
- fever
- abdominal pain or tenderness
This may happen months after the last dose of medication. If this occurs, stop taking and contact your doctor right away.
- severe, persistent, watery or bloody diarrhea with or without
Symptom / effect | Talk to your healthcare professional Only if severe | Talk to your healthcare professional In all cases | Stop taking drug and get immediate medical help |
---|---|---|---|
Very Common | |||
Liver problems with symptoms such a yellowing skin or eyes, abdominal pain, nausea, vomiting | ✔ | ✔ | |
Common | |||
Diarrhea | ✔ | ||
Rash | ✔ | ||
Rare | |||
Skin reactions: itching | ✔ | ||
Not Known | |||
Clostridium difficile associated disease (bowel inflammation), with symptoms such as persistent or severe diarrhea, abdominal pain, nausea and vomiting | ✔ | ||
Injection site reactions with symptoms as pain, redness and skin irritation | ✔ | ||
Serious allergic (hypersensitivity) reaction with symptoms such as swelling of eyes, mouth, throat, difficulty breathing, blistering or peeling skin, rash, itching | ✔ |
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your health care professional.
How to store
The healthcare professional will store Clindamycin IV Infusion minibags under appropriate conditions (15C to 25C).
Reporting side effects
You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information.
3 ways to report:
- Online at MedEffect;
- By calling 1-866-234-2345 (toll-free);
- By completing a Consumer Side Effect Reporting Form and sending it by:
- Fax to 1-866-678-6789 (toll-free), or
- Mail to: Canada Vigilance Program
Health Canada, Postal Locator 1908C
Ottawa, ON
K1A 0K9
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://hc-sc.gc.ca/index-eng.php); or by calling Sandoz Canada Inc. at: 1-800-361-3062
or by written request at:
145 Jules-Léger
Boucherville QC
J4B 7K8
or by e-mail at:
medinfo@sandoz.com
This leaflet was prepared by Sandoz Canada Inc.
Last revised: December 29, 2016